PTGDR rs1162394: Understanding Genetic Links to Asthma
The rs1162394 variant is a single-nucleotide polymorphism located in the promoter region of the PTGDR gene. Research suggests this variant may influence how the gene is expressed, potentially impacting susceptibility to asthma and allergic inflammation.
What each genotype means
Typical PTGDR promoter activity
This genotype represents the common form of the PTGDR promoter region. Research suggests this configuration is associated with baseline transcriptional activity of the prostaglandin D2 receptor, which plays a role in mediating allergic inflammation. Because associations with asthma susceptibility are complex and often depend on specific haplotypes rather than single variants, this result should not be used to predict individual health outcomes.
This is the most common genotype in many populations, particularly among those of European ancestry.
Modified PTGDR promoter activity
Carrying one copy of the T allele at this position may influence the transcriptional activity of the PTGDR gene. Some studies have linked specific PTGDR promoter variants to differences in susceptibility to asthma and allergic inflammation, though findings have been inconsistent across different ethnic groups. Please discuss any concerns regarding respiratory health or medication response with your clinician.
This heterozygous genotype is found in a significant portion of the population, with the minor allele frequency typically ranging between 0.15 and 0.25 in European cohorts.
Altered PTGDR promoter activity
This genotype involves two copies of the T allele, which has been investigated for its potential to modify PTGDR gene expression. While some meta-analyses have suggested an association between PTGDR promoter polymorphisms and asthma susceptibility in European adults, the evidence remains mixed and context-dependent. This information is for educational purposes and does not constitute a medical diagnosis or a prediction of disease risk.
This genotype is less common than the CC or CT configurations, occurring in a smaller subset of the population.
What is rs1162394?
The rs1162394 variant is a specific change in the DNA sequence located within the promoter region of the PTGDR gene on chromosome 14. A promoter region acts as a control switch for a gene, determining how much of a protein is produced by the cell. Because rs1162394 sits in this regulatory area, scientists have investigated whether it alters the binding of transcription factors—proteins that turn genes on or off. By changing the efficiency of this switch, the variant may lead to differences in the amount of prostaglandin D2 receptor produced in various tissues. This makes it a focus for researchers studying how genetic architecture contributes to complex, multi-factorial conditions like asthma, where immune system regulation plays a central role.
The Role of the PTGDR Gene
The PTGDR gene provides instructions for creating the prostaglandin D2 receptor, which is found on the surface of various immune cells. When prostaglandin D2 binds to this receptor, it triggers a signaling cascade that typically results in the accumulation of cyclic AMP (cAMP) within the cell. This process is generally associated with the inhibition of certain immune responses, including the activity of Th1 lymphocytes and other inflammatory cells. By modulating these signals, the receptor helps maintain a balance in the immune system. Because of its role in dampening inflammation, researchers have long hypothesized that variations in the PTGDR gene could disrupt this regulatory mechanism, potentially leaving the airways more susceptible to the chronic inflammation characteristic of asthma.
Research and Evidence
Scientific evidence linking rs1162394 and other PTGDR variants to asthma is considered moderate. Early studies, such as those published in the New England Journal of Medicine, identified that specific haplotypes—combinations of variants including those in the promoter region—were associated with asthma diagnoses in both white and black populations. Meta-analyses have further explored these associations, suggesting that certain promoter polymorphisms may confer susceptibility to asthma, particularly in European populations. However, the field has also seen contradictory findings, with some studies suggesting the receptor might have complex, context-dependent roles in inflammation. It is important to note that asthma is a polygenic trait, meaning it is influenced by many genes and environmental factors. Therefore, this single variant is only one small piece of a much larger, complex biological puzzle.
What You Can Do With This Information
Genetic information regarding variants like rs1162394 is primarily used for research purposes to better understand the biological pathways of disease. It is not a diagnostic tool, and having a specific genotype does not mean an individual will develop asthma, nor does it guarantee protection from it. Asthma is a clinical diagnosis made by healthcare professionals based on symptoms, lung function tests, and medical history. If you are concerned about your respiratory health or have questions about your genetic profile, the most appropriate step is to consult with a physician or a genetic counselor. They can provide context based on your personal health history and help you understand how to manage your health effectively. Never use genetic data to make independent medical decisions or to alter any prescribed treatments.
How common is this variant?
The minor allele frequency for rs1162394 is approximately 0.15–0.25 in European populations. Frequencies can vary significantly across different global ancestries.
Frequently asked questions
Does having the rs1162394 variant mean I have asthma?
No. Genetic variants are just one of many factors that contribute to the risk of developing asthma. A diagnosis of asthma is based on clinical evaluation by a doctor, not on a single genetic marker.
Is rs1162394 used for medical testing?
Currently, this variant is primarily used in scientific research to understand the genetic basis of asthma. It is not typically used in routine clinical diagnostic testing.
Can I change my risk associated with this gene?
While you cannot change your DNA, you can manage your health by working with a healthcare provider to identify and avoid environmental triggers for asthma. Lifestyle factors and medical management are the primary ways to control asthma symptoms.
Where can I learn more about my own genetic risk?
If you have questions about your genetic risk for asthma, you should speak with a board-certified genetic counselor or your primary care physician. They can help interpret your health history and provide personalized guidance.
Sources & further reading
Educational information only, last refreshed 9/26/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs1162394?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29